Skip to main content

Table 3 Results of univariate analysis concerning 5-year survival of the LUSC patients

From: Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis

Clinical features

Patients

(N = 73)

5-year survival (%)

P

patients

Rate (%)

Gender

   

0.711

 Male

66

26

39.4

 

 Female

7

3

42.9

Age

   

0.451

  < 60

23

10

43.5

 

 ≥ 60

50

19

38.0

Differentiation

   

0.928

 Good

3

2

66.7

 

 Moderate

53

21

39.6

 Poor

17

6

35.3

pT classification

   

0.465

 pT1

12

6

50.0

 

 pT2

32

13

40.6

 pT3

29

10

34.5

pN

   

0.001

 −

27

19

70.4

 

   + 

46

10

21.7

 

pTNM stage

   

0.001

 pI

12

9

75.0

 

 pII

30

15

50.0

 pIIIa

31

5

16.1

YTHDF2 expression

   

0.002

 Low

29

16

55.2

 

 High

44

13

29.5

  1. P-Log-rank test; pT classification, tumor size; pN, lymph node metastasis and pTNM stage, tumor stage